Endocrine Disorders: Evaluation and Management

  • Author: Todd T. Brown, MD (More Info)
  • Editors in Chief: Daniel R. Kuritzkes, MD; Joseph J. Eron, Jr., MD
  • Last Reviewed: 11/14/16 (What's New)

Summary

  • Pramlintide is approved for use in type 1 or insulin-treated type 2 diabetes patients not achieving adequate control with basal and prandial insulin

Action required